Most recent by Ashley Killen
Massage therapy may benefit young patients with cancer or sickle cell disease
Massage therapy can benefit young patients with cancer or hematologic conditions, according to retrospective study results.
Haptoglobin gene expression linked to cardiomyopathy among childhood cancer survivors
Haptoglobin gene expression in the blood appeared associated with anthracycline-related cardiomyopathy among childhood cancer survivors, according to study results.
Trial represents ‘first foray’ into molecularly-guided approach to bladder sparing
A prospective phase 2 trial that evaluated risk-enabled therapy after neoadjuvant chemotherapy for muscle-invasive bladder cancer failed to meet a prespecified threshold of noninferiority, according to study results.
Study of vaccine for triple-negative breast cancer moves into next phase
Researchers at Cleveland Clinic intend to expand their study of a novel vaccine designed to prevent triple-negative breast cancer.
Healio | HemOnc Today announces nominees for Disruptive Innovators Awards in oncology, hematology
Healio | HemOnc Today is excited to announce the nominees for its second annual Disruptive Innovators Awards in oncology and hematology.
Data show ‘alarming’ shift in colorectal cancer to advanced stage, younger age at diagnosis
A greater percentage of colorectal cancer cases in the United States are being diagnosed at advanced stages, according to an American Cancer Society report.
Essential oils reduce nausea, vomiting after bone marrow transplantation
Pure essential oils can reduce incidence of chemotherapy-induced nausea and vomiting among individuals who undergo bone marrow transplant, according to study results.
Adjuvant chemotherapy extends survival in pancreatic cancer
Adjuvant chemotherapy appeared associated with a significant survival benefit among patients with pancreatic ductal adenocarcinoma who underwent multiagent neoadjuvant chemotherapy and resection, according to study results.
Chemotherapy-induced peripheral neuropathy common after taxane therapy for breast cancer
Two-thirds of patients with breast cancer treated with taxane-based therapy experienced clinically meaningful chemotherapy-induced peripheral neuropathy symptoms during the first year of treatment, according to prospective study results.
Itacitinib appears effective for acute graft-versus-host disease
A short course of itacitinib induced high response rates among patients with low-risk acute graft-versus-host disease, according to study results.